Vitiligo: A comprehensive overview: Part II: Treatment options and approach to treatment

Journal of the American Academy of Dermatology

Volumn 65, Issue 3, 2011, Pages 493-514

  Felsten, Lesley M ^a   Alikhan, Ali ^a   Petronic Rosic, Vesna ^b  

^a MACNEAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

antioxidants; autoimmune; autologous melanocyte suspension graft; biologic agents; camouflage; chemophototherapy; corticosteroids; depigmentation; depigmented; hypopigmentation; hypopigmented; laser; leukoderma; macule; melanocyte; melanosome; phototherapy; psychotherapy; punch graft; split thickness skin graft; suction blister graft; topical calcineurin inhibitors; vitamin D3 analogs; vitiligo

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; AUTOANTIBODY; BERGAPTEN; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CATALASE; CORTICOSTEROID; COSMETIC; CYTOKINE; DEXAMETHASONE; FLUTICASONE; FUROCOUMARIN; HYDROCORTISONE; KHELLIN; METHIONINE SULFOXIDE REDUCTASE; METHOXSALEN; METHYLPREDNISOLONE; PHENYLALANINE; PIMECROLIMUS; POLYPODIUM LEUCOTOMOS EXTRACT; PSORALEN; SUNSCREEN; SUPEROXIDE DISMUTASE; TACROLIMUS; THIOCTIC ACID; TRIMETHYLPSORALEN; UNINDEXED DRUG; XENON;

ACNE; ACTINIC KERATOSIS; ADRENAL INSUFFICIENCY; AGITATION; ATROPHY; AUTOLOGOUS MELANOCYTE SUSPENSION TRANSPLANT; BIOSKIN; BLISTER; BLISTER GRAFT; BURN; CALIBRATION; CANCER RISK; CELL DESTRUCTION; CELL PROLIFERATION; CELL TRANSPLANTATION; COBBLE STONING; COMPLICATION; DEPIGMENTATION; DEVICE; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EDEMA; EPIDERMAL ATROPHY; ERYTHEMA; EXCIMER LASER; FOLLICULITIS; GINKGO BILOBA; GRAFT FAILURE; HEADACHE; HEALTH CARE COST; HELIUM NEON LASER; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPIGMENTATION; HYPERTRANSAMINASEMIA; HYPERTRICHOSIS; IMMUNE RESPONSE; INFECTION; INFLAMMATORY CELL; INSOMNIA; KERATINOCYTE; KOEBNERIZATION; LEOPARD SYNDROME; MACROPHAGE; MELANOCYTE; MELANOMA; MENSTRUATION DISORDER; MONOCHROMATIC EXCIMER LASER; MONOTHERAPY; NARROWBAND ULTRAVIOLET B LIGHT PHOTOTHERAPY; NAUSEA; OXIDATIVE STRESS; PATHOGENESIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PHOTOTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; PSYCHOTHERAPY; PUNCH GRAFT; REVIEW; RISK ASSESSMENT; SCAR; SIDE EFFECT; SKIN GRAFT; SKIN IRRITATION; SKIN NECROSIS; SPLIT THICKNESS SKIN GRAFT; STEROID FOLLICULITIS; STRIA DISTENSAE; SURGICAL TECHNIQUE; SYSTEMIC THERAPY; T LYMPHOCYTE; TATTOO; TELANGIECTASIA; TISSUE GRAFT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; VARIEGATED PIGMENTATION; VITILIGO; WEIGHT GAIN;

HUMANS; VITILIGO;

EID: 80051760750     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.10.043     Document Type: Review

References (193)

1. S. Dave, D.M. Thappa, and M. Dsouza Clinical predictors of outcome in vitiligo Indian J Dermatol Venereol Leprol 68 2002 323 325
2. S.E. Cockayne, A.G. Messenger, and D.J. Gawkrodger Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well J Am Acad Dermatol 46 2002 964 965
3. J. Kumari Vitiligo treated with topical clobetasol propionate Arch Dermatol 120 1984 631 635 (Pubitemid 14140281)
4. S.K. Hann, M.Y. Cho, S. Im, and Y.K. Park Treatment of vitiligo with oral 5-methoxypsoralen J Dermatol 18 1991 324 329
5. A. Lassus, K. Halme, A. Eskelinen, A. Ranki, P. Puska, and O. Salo Treatment of vitiligo with oral methoxsalen and UVA Photodermatol 1 1984 170 173 (Pubitemid 14028180)
6. N.B. Silverberg, P. Lin, L. Travis, J. Farley-Li, A.J. Mancini, and A.M. Wagner Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases J Am Acad Dermatol 51 2004 760 766 (Pubitemid 39516891)
7. V. Brazzelli, M. Antoninetti, S. Palazzini, T. Barbagallo, A. De Silvestri, and G. Borroni Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy J Eur Acad Dermatol Venereol 21 2007 1369 1374 (Pubitemid 350020144)
8. A.M. Badri, P.M. Todd, J.J. Garioch, J.E. Gudgeon, D.G. Stewart, and R.B. Goudie An immunohistological study of cutaneous lymphocytes in vitiligo J Pathol 170 1993 149 155 (Pubitemid 23192367)
9. R. van den Wijngaard, A. Wankowicz-Kalinska, C. Le Poole, B. Tigges, W. Westerhof, and P. Das Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site Lab Invest 80 2000 1299 1309 (Pubitemid 30637070)
10. S.K. Hann, H.I. Kim, S. Im, Y.K. Park, J. Cui, and J.C. Bystryn The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients J Dermatol Sci 6 1993 201 205 (Pubitemid 24024409)
11. S.S. Bleehen The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies Br J Dermatol 94 suppl 12 1976 43 50
12. E. Kandil Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol - a double-blind trial Br J Dermatol 91 1974 457 460
13. J. Kwinter, J. Pelletier, A. Khambalia, and E. Pope High-potency steroid use in children with vitiligo: a retrospective study J Am Acad Dermatol 56 2007 236 241 (Pubitemid 46074239)
14. V. Lepe, B. Moncada, J.P. Castanedo-Cazares, M.B. Torres-Alvarez, C.A. Ortiz, and A.B. Torres-Rubalcava A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo Arch Dermatol 139 2003 581 585 (Pubitemid 36576373)
15. B. Coskun, Y. Saral, and D. Turgut Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo Eur J Dermatol 15 2005 88 91 (Pubitemid 40434632)
16. W. Westerhof, L. Nieuweboer-Krobotova, P.G. Mulder, and E.J. Glazenburg Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo Arch Dermatol 135 1999 1061 1066 (Pubitemid 29430496)
17. S. Seiter, S. Ugurel, W. Tilgen, and U. Reinhold Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo Int J Dermatol 39 2000 624 627
18. S. Radakovic-Fijan, A.M. Furnsinn-Friedl, H. Honigsmann, and A. Tanew Oral dexamethasone pulse treatment for vitiligo J Am Acad Dermatol 44 2001 814 817 (Pubitemid 32391170)
19. S.M. Kim, H.S. Lee, and S.K. Hann The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients Int J Dermatol 38 1999 546 550 (Pubitemid 29331937)
20. N. Rath, H.K. Kar, and S. Sabhnani An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo Indian J Dermatol Venereol Leprol 74 2008 357 360
21. A.P. Castro Calcineurin inhibitors in the treatment of allergic dermatitis J Pediatr (Rio J) 82 5 suppl 2006 S166 S172
22. P.E. Grimes, R. Morris, E. Avaniss-Aghajani, T. Soriano, M. Meraz, and A. Metzger Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines J Am Acad Dermatol 51 2004 52 61 (Pubitemid 38887475)
23. C.C. Lan, G.S. Chen, M.H. Chiou, C.S. Wu, C.H. Chang, and H.S. Yu FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo Br J Dermatol 153 2005 498 505
24. A.E. Xu, D.M. Zhang, X.D. Wei, B. Huang, and L.J. Lu Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo Int J Dermatol 48 2009 86 90
25. A. Hartmann, E.B. Brocker, and H. Hamm Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study Acta Derm Venereol 88 2008 474 479
26. E.A. Tanghetti Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series Cutis 71 2003 158 162 (Pubitemid 38010838)
27. F.A. Mayoral, J.M. Vega, H. Stavisky, C.L. McCormick, and A. Parneix-Spake Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo J Drugs Dermatol 6 2007 517 521
28. H. Seirafi, F. Farnaghi, A. Firooz, A. Vasheghani-Farahani, N.S. Alirezaie, and Y. Dowlati Pimecrolimus cream in repigmentation of vitiligo Dermatology 214 2007 253 259 (Pubitemid 46457612)
29. A. Hartmann, E.B. Brocker, and H. Hamm Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion J Deutschen Dermatologischen Gesellschaft 6 2008 383 385 (Pubitemid 351712819)
30. C.W. Choi, S.E. Chang, H. Bak, J.H. Choi, H.S. Park, and C.H. Huh Topical immunomodulators are effective for treatment of vitiligo J Dermatol 35 2008 503 507
31. D. Mehrabi, and A.G. Pandya A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo Arch Dermatol 142 2006 927 929 (Pubitemid 44079798)
32. D. Fai, N. Cassano, and G.A. Vena Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients J Eur Acad Dermatol Venereol 21 2007 916 920 (Pubitemid 47103721)
33. I. Esfandiarpour, A. Ekhlasi, S. Farajzadeh, and S. Shamsadini The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial J Dermatolog Treat 20 2009 14 18
34. T. Passeron, N. Ostovari, W. Zakaria, E. Fontas, J.C. Larrouy, and J.P. Lacour Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo Arch Dermatol 140 2004 1065 1069 (Pubitemid 39223113)
35. D. De, and A.J. Kanwar Tacrolimus-induced hyperpigmentation in a patch of vitiligo Skinmed 7 2008 93 94
36. L. Bakos, and R.M. Bakos Focal acne during topical tacrolimus therapy for vitiligo Arch Dermatol 143 2007 1223 1224 (Pubitemid 47443398)
37. A.Z. Kawalek, J.M. Spencer, and R.G. Phelps Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study Dermatol Surg 30 2 pt 1 2004 130 135 (Pubitemid 38313998)
38. D. Thaci, and R. Salgo Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies Clin Dermatol 28 2010 52 56
39. A.D. McCollum, A. Paik, and L.F. Eichenfield The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis Pediatr Dermatol 27 2010 425 436
40. US Food and Drug Administration Web site. Available from: www.fda.gov. Accessed June 1, 2011.
41. J. Kristl, P. Slanc, M. Krasna, A. Berlec, M. Jeras, and B. Strukelj Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2 Pharm Res 25 2008 521 529 (Pubitemid 351357721)
42. L. Adorini, and G. Penna Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists Hum Immunol 70 2009 345 352
43. S.A. Birlea, G.E. Costin, and D.A. Norris Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation Curr Drug Targets 9 2008 345 359 (Pubitemid 351836434)
44. D. Parsad, R. Saini, and R. Nagpal Calcipotriol in vitiligo: a preliminary study Pediatr Dermatol 16 1999 317 320 (Pubitemid 29383171)
45. A.M. Gargoom, G.A. Duweb, A.H. Elzorghany, M. Benghazil, and O.O. Bugrein Calcipotriol in the treatment of childhood vitiligo Int J Clin Pharmacol Res 24 2004 11 14 (Pubitemid 39535380)
46. M.S. Kumaran, I. Kaur, and B. Kumar Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo J Eur Acad Dermatol Venereol 20 2006 269 273
47. L.B. Travis, and N.B. Silverberg Calcipotriene and corticosteroid combination therapy for vitiligo Pediatr Dermatol 21 2004 495 498 (Pubitemid 39050630)
48. E. Arca, H.B. Tastan, A.H. Erbil, E. Sezer, E. Koc, and Z. Kurumlu Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo J Dermatol 33 2006 338 343 (Pubitemid 43943367)
49. A. Hartmann, C. Lurz, H. Hamm, E.B. Brocker, and U.B. Hofmann Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo Int J Dermatol 44 2005 736 742 (Pubitemid 41301007)
50. S. Ada, S. Sahin, G. Boztepe, A. Karaduman, and F. Kolemen No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo Photodermatol Photoimmunol Photomed 21 2005 79 83 (Pubitemid 40425651)
51. E.O. Goktas, F. Aydin, N. Senturk, M.T. Canturk, and A.Y. Turanli Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo J Eur Acad Dermatol Venereol 20 2006 553 557
52. O. Ermis, E. Alpsoy, L. Cetin, and E. Yilmaz Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study Br J Dermatol 145 2001 472 475 (Pubitemid 32953706)
53. C.S. Wu, C.C. Lan, L.F. Wang, G.S. Chen, C.S. Wu, and H.S. Yu Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo Br J Dermatol 156 2007 122 129
54. M.B. Abdel-Naser, S.K. Hann, and J.C. Bystryn Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation Arch Dermatol 133 1997 1530 1533 (Pubitemid 27525731)
55. A.L. Ponsonby, R.M. Lucas, and I.A. van der Mei UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis Photochem Photobiol 81 2005 1267 1275 (Pubitemid 43035835)
56. J.P. Ortonne, D.M. MacDonald, A. Micoud, and J. Thivolet PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study Br J Dermatol 101 1979 1 12 (Pubitemid 10134309)
57. C.H. Kao, and H.S. Yu Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in vitro J Invest Dermatol 98 1992 734 740
58. D. Parsad, R. Pandhi, S. Dogra, and B. Kumar Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches J Am Acad Dermatol 50 2004 63 67 (Pubitemid 38095653)
59. [Homepage on the Internet]. Available from: http://www. clinicalpharmacology.com.
60. M. El-Mofty, W. Mostafa, R. Youssef, M. El-Fangary, A.Z. Elramly, and D. Mahgoub Ultraviolet A in vitiligo Photodermatol Photoimmunol Photomed 22 2006 214 216 (Pubitemid 44089002)
61. V. De Francesco, G. Stinco, S. Laspina, M.E. Parlangeli, L. Mariuzzi, and P. Patrone Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo Eur J Dermatol 18 2008 292 296 (Pubitemid 351821232)
62. O. Welsh, M.E. Herz-Ruelas, M. Gomez, and J. Ocampo-Candiani Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area Int J Dermatol 48 2009 529 534
63. A.J. Kanwar, and S. Dogra Narrow-band UVB for the treatment of generalized vitiligo in children Clin Exp Dermatol 30 2005 332 336 (Pubitemid 40835321)
64. A.J. Kanwar, S. Dogra, D. Parsad, and B. Kumar Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy Int J Dermatol 44 2005 57 60 (Pubitemid 40201994)
65. M.D. Njoo, J.D. Bos, and W. Westerhof Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy J Am Acad Dermatol 42 2 pt 1 2000 245 253 (Pubitemid 30469622)
66. G.Y. Chen, M.M. Hsu, H.K. Tai, T.C. Chou, C.L. Tseng, and H.Y. Chang Narrow-band UVB treatment of vitiligo in Chinese J Dermatol 32 2005 793 800 (Pubitemid 41703755)
67. M. El Mofty, W. Mostafa, S. Esmat, R. Youssef, O. Azzam, and N. Hunter Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies Photodermatol Photoimmunol Photomed 22 2006 6 11 (Pubitemid 43733213)
68. M.E. Mofty, H. Zaher, S. Esmat, R. Youssef, Z. Shahin, and D. Bassioni PUVA and PUVB in vitiligo - are they equally effective? Photodermatol Photoimmunol Photomed 17 2001 159 163 (Pubitemid 32677595)
69. A. Bhatnagar, A.J. Kanwar, D. Parsad, and D. De Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study J Eur Acad Dermatol Venereol 21 2007 1381 1385 (Pubitemid 350020146)
70. D. Parsad, A.J. Kanwar, and B. Kumar Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo J Eur Acad Dermatol Venereol 20 2006 175 177 (Pubitemid 43740518)
71. J.A. Kenney Jr. Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation Arch Dermatol 103 1971 475 480
72. I.L. Wildfang, F.K. Jacobsen, and K. Thestrup-Pedersen PUVA treatment of vitiligo: a retrospective study of 59 patients Acta Derm Venereol 72 1992 305 306
73. S. Valkova, M. Trashlieva, and P. Christova Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA Clin Exp Dermatol 29 2004 180 184 (Pubitemid 38367205)
74. M.B. Abdel Naser, U. Wollina, M. El Okby, and S. El Shiemy Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin Clin Exp Dermatol 29 2004 380 382 (Pubitemid 38980368)
75. H. Herr, H.J. Cho, and S. Yu Burns caused by accidental overdose of photochemotherapy (PUVA) Burns 33 2007 372 375 (Pubitemid 46428483)
76. S.E. Shephard, and R.G. Panizzon Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy Dermatology 199 1999 106 112 (Pubitemid 29494783)
77. H.S. Park, Y.S. Lee, and D.K. Chun Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy J Eur Acad Dermatol Venereol 17 2003 578 580 (Pubitemid 37138903)
78. R.V. Patel, L.N. Clark, M. Lebwohl, and J.M. Weinberg Treatments for psoriasis and the risk of malignancy J Am Acad Dermatol 60 2009 1001 1017
79. B. Lindelof Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits? Drug Saf 20 1999 289 297 (Pubitemid 29196908)
80. R.M. Hearn, A.C. Kerr, K.F. Rahim, J. Ferguson, and R.S. Dawe Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy Br J Dermatol 159 2008 931 935
81. B. Ortel, V. Petronic-Rosic, and P. Calzavara-Pinton Phototherapeutic options for vitiligo J. Krutmann, H. Hönigsmann, C.A. Elmets, P.R. Bergstresser, Dermatological phototherapy and photodiagnostic methods 2009 Springer Heidelberg 151 183
82. J.M. Spencer, and S.M. Hadi The excimer lasers J Drugs Dermatol 3 2004 522 525
83. Z. Shen, T.W. Gao, L. Chen, L. Yang, Y.C. Wang, and L.C. Sun Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck Photomed Laser Surg 25 2007 418 427 (Pubitemid 350059048)
84. G. Leone, P. Iacovelli, A. Paro Vidolin, and M. Picardo Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study J Eur Acad Dermatol Venereol 17 2003 531 537 (Pubitemid 37138890)
85. N. Ostovari, T. Passeron, W. Zakaria, E. Fontas, J.C. Larouy, and J.F. Blot Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response Lasers Surg Med 35 2004 152 156 (Pubitemid 39150415)
86. S.M. Hadi, J.M. Spencer, and M. Lebwohl The use of the 308-nm excimer laser for the treatment of vitiligo Dermatol Surg 30 2004 983 986 (Pubitemid 38890905)
87. S.R. Al-Otaibi, V.B. Zadeh, A.H. Al-Abdulrazzaq, S.M. Tarrab, H.A. Al-Owaidi, and R. Mahrous Using a 308-nm excimer laser to treat vitiligo in Asians Acta Dermatovenerol Alp Panonica Adriat 18 2009 13 19
88. A. Hofer, A.S. Hassan, F.J. Legat, H. Kerl, and P. Wolf The efficacy of excimer laser (308 nm) for vitiligo at different body sites J Eur Acad Dermatol Venereol 20 2006 558 564
89. A. Hofer, A.S. Hassan, F.J. Legat, H. Kerl, and P. Wolf Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients Br J Dermatol 152 2005 981 985 (Pubitemid 40704939)
90. S. Hadi, P. Tinio, K. Al-Ghaithi, H. Al-Qari, M. Al-Helalat, and M. Lebwohl Treatment of vitiligo using the 308-nm excimer laser Photomed Laser Surg 24 2006 354 357 (Pubitemid 44115218)
91. S.B. Hong, H.H. Park, and M.H. Lee Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study J Korean Med Sci 20 2005 273 278
92. M. Casacci, P. Thomas, A. Pacifico, A. Bonnevalle, A. Paro Vidolin, and G. Leone Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo - a multicentre controlled study J Eur Acad Dermatol Venereol 21 2007 956 963 (Pubitemid 47103727)
93. F. Sassi, S. Cazzaniga, G. Tessari, L. Chatenoud, A. Reseghetti, and L. Marchesi Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck Br J Dermatol 159 2008 1186 1191
94. S.M. Goldinger, R. Dummer, P. Schmid, G. Burg, B. Seifert, and S. Lauchli Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo J Eur Acad Dermatol Venereol 21 2007 504 508 (Pubitemid 46454904)
95. T. Lu-yan, F. Wen-wen, X. Lei-hong, J. Yi, and Z. Zhi-zhong Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo Photodermatol Photoimmunol Photomed 22 2006 310 314 (Pubitemid 44712308)
96. R. Saraceno, S.P. Nistico, E. Capriotti, and S. Chimenti Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study Dermatol Ther 22 2009 391 394
97. T. Lotti, G. Buggiani, M. Troiano, G.B. Assad, J. Delescluse, and V. De Giorgi Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects Dermatol Ther 21 suppl 1 2008 S20 S26
98. C.S. Wu, S.C. Hu, C.C. Lan, G.S. Chen, W.H. Chuo, and H.S. Yu Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions Kaohsiung J Med Sci 24 2008 180 189 (Pubitemid 351656040)
99. C.C. Lan, C.S. Wu, M.H. Chiou, P.C. Hsieh, and H.S. Yu Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro J Invest Dermatol 126 2006 2119 2126
100. H.S. Yu, C.S. Wu, C.L. Yu, Y.H. Kao, and M.H. Chiou Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo J Invest Dermatol 120 2003 56 64
101. E. Adisen, F. Karaca, M. Oztas, and M.A. Gurer Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema Clin Exp Dermatol 33 2008 344 345 (Pubitemid 351550626)
102. A. Kreuter, T. Gambichler, A. Avermaete, T. Jansen, P. Altmeyer, and G. von Kobyletzki Localized vitiligo successfully treated with cream-psoralen + ultraviolet A J Eur Acad Dermatol Venereol 15 2001 357 358 (Pubitemid 33014853)
103. G. Carlie, N.B. Ntusi, P.A. Hulley, and S.H. Kidson KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro Br J Dermatol 149 2003 707 717 (Pubitemid 37411990)
104. G. Orecchia, and L. Perfetti Photochemotherapy with topical khellin and sunlight in vitiligo Dermatology 184 1992 120 123
105. A. Abdel-Fattah, M.N. Aboul-Enein, G.M. Wassel, and B.S. El-Menshawi An approach to the treatment of vitiligo by khellin Dermatologica 165 1982 136 140 (Pubitemid 12093629)
106. A. Hofer, H. Kerl, and P. Wolf Long-term results in the treatment of vitiligo with oral khellin plus UVA Eur J Dermatol 11 2001 225 229 (Pubitemid 32472674)
107. B. Ortel, A. Tanew, and H. Honigsmann Treatment of vitiligo with khellin and ultraviolet A J Am Acad Dermatol 18 4 pt 1 1988 693 701
108. T. Jansen, M. Megahed, E. Holzle, and G. Plewig Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo Acta Derm Venereol 75 1995 232 233
109. K.U. Schallreuter, B. Chavan, H. Rokos, N. Hibberts, A. Panske, and J.M. Wood Decreased phenylalanine uptake and turnover in patients with vitiligo Mol Genet Metab 86 suppl 1 2005 S27 S33
110. W. Westerhof, I. Groot, S.R. Krieg, J.D. Bos, and R.H. Cormane Langerhans's cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation Acta Derm Venereol 66 1986 259 262 (Pubitemid 16115869)
111. G.R. Kuiters, J.M. Hup, A.H. Siddiqui, and R.H. Cormane Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the caribbean island of curacao NA J Trop Med Hyg 89 1986 149 155 (Pubitemid 17175606)
112. C.H. Schulpis, C. Antoniou, T. Michas, and J. Strarigos Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo Pediatr Dermatol 6 1989 332 335 (Pubitemid 20115783)
113. A.H. Siddiqui, L.M. Stolk, R. Bhaggoe, R. Hu, R.B. Schutgens, and W. Westerhof L-phenylalanine and UVA irradiation in the treatment of vitiligo Dermatology 188 1994 215 218 (Pubitemid 24055319)
114. B. Thiele, and G.K. Steigleder Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation [in German] Z Hautkr 62 1987 519 523 (Pubitemid 17043705)
115. F. Camacho, and J. Mazuecos Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience Arch Dermatol 135 1999 216 217 (Pubitemid 29098382)
116. C. Antoniou, H. Schulpis, T. Michas, A. Katsambas, N. Frajis, and S. Tsagaraki Vitiligo therapy with oral and topical phenylalanine with UVA exposure Int J Dermatol 28 1989 545 547 (Pubitemid 19256565)
117. F. Camacho, and J. Mazuecos Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight - a new study for the treatment of vitiligo J Drugs Dermatol 1 2002 127 131
118. D. Greiner, F.R. Ochsendorf, and R. Milbradt Vitiligo therapy with phenylalanine/UV A. Catamnestic studies after five years [in German] Hautarzt 45 1994 460 463 (Pubitemid 24232639)
119. Z. Zhou, C.Y. Li, K. Li, T. Wang, B. Zhang, and T.W. Gao Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo Br J Dermatol 161 2009 504 509
120. M.L. Dell'sAnna, A. Mastrofrancesco, R. Sala, M. Venturini, M. Ottaviani, and A.P. Vidolin Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial Clin Exp Dermatol 32 2007 631 636 (Pubitemid 47609756)
121. J.E. Rojas-Urdaneta, and A.G. Poleo-Romero Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo [in Spanish] Invest Clin 48 2007 21 31 (Pubitemid 46718383)
122. D. Parsad, R. Pandhi, and A. Juneja Effectiveness of oral ginkgo biloba in treating limited, slowly spreading vitiligo Clin Exp Dermatol 28 2003 285 287 (Pubitemid 36713819)
123. M. Elgoweini, and N. Nour El Din Response of vitiligo to narrowband ultraviolet B and oral antioxidants J Clin Pharmacol 49 2009 852 855
124. M. Akyol, V.K. Celik, S. Ozcelik, M. Polat, M. Marufihah, and A. Atalay The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA Eur J Dermatol 12 2002 24 26 (Pubitemid 34131134)
125. K.U. Schallreuter, J.M. Wood, K.R. Lemke, and C. Levenig Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients Dermatology 190 1995 223 229
126. E.P. Yuksel, F. Aydin, N. Senturk, T. Canturk, and A.Y. Turanli Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients Eur J Dermatol 19 2009 341 344
127. D.C. Patel, A.V. Evans, and J.L. Hawk Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study Clin Exp Dermatol 27 2002 641 644 (Pubitemid 35454220)
128. K.U. Schallreuter, J. Moore, S. Behrens-Williams, A. Panske, and M. Harari Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase (PC-KUS) Int J Dermatol 41 2002 482 487 (Pubitemid 35021486)
129. G. Sanclemente, J.J. Garcia, J.J. Zuleta, C. Diehl, C. Correa, and R. Falabella A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo J Eur Acad Dermatol Venereol 22 2008 1359 1364
130. S. Gonzalez, M.A. Pathak, J. Cuevas, V.G. Villarrubia, and T.B. Fitzpatrick Topical or oral administration with an extract of polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin Photodermatol Photoimmunol Photomed 13 1997 50 60 (Pubitemid 27445908)
131. M.A. Middelkamp-Hup, J.D. Bos, F. Rius-Diaz, S. Gonzalez, and W. Westerhof Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: a randomized double-blind placebo-controlled study J Eur Acad Dermatol Venereol 21 2007 942 950 (Pubitemid 47103725)
132. N. Tsiskarishvili Cuprum sulfate and vitix in the treatment of vitiligo in children [in Russian] Georgian Med News 121 2005 48 51
133. W.Y. Tang, L.Y. Chan, and K.K. Lo Treatment of vitiligo with autologous epidermal transplantation using the roofs of suction blisters Hong Kong Med J 4 1998 219 224 (Pubitemid 28381412)
134. M. Koga Epidermal grafting using the tops of suction blisters in the treatment of vitiligo Arch Dermatol 124 1988 1656 1658 (Pubitemid 18260860)
135. C. Laxmisha, and D.M. Thappa Reliable site for suction blister induction and harvesting Indian J Dermatol Venereol Leprol 71 2005 321 324 (Pubitemid 41376753)
136. M. Sachdev, and D.S. Krupashankar Suction blister grafting for stable vitiligo using pulsed erbium: YAG laser ablation for recipient site Int J Dermatol 39 2000 471 473 (Pubitemid 30461802)
137. A.C. Fernandez-Obregon Clinical management with efalizumab of a patient with psoriasis and comorbid vitiligo J Drugs Dermatol 7 2008 679 681
138. C.Y. Kim, T.J. Yoon, and T.H. Kim Epidermal grafting after chemical epilation in the treatment of vitiligo Dermatol Surg 27 2001 855 856
139. S. Gupta, S. Shroff, and S. Gupta Modified technique of suction blistering for epidermal grafting in vitiligo Int J Dermatol 38 1999 306 309 (Pubitemid 29189640)
140. N. Hatchome, T. Kato, and H. Tagami Therapeutic success of epidermal grafting in generalized vitiligo is limited by the koebner phenomenon J Am Acad Dermatol 22 1990 87 91 (Pubitemid 20035726)
141. J.T. Lim Repigmentation of vitiligo with autologous blister-induced epidermal grafts Ann Acad Med Singapore 28 1999 824 828
142. S.S. Awad, H. Abdel-Raof, W. Hosam El-Din, and M. El-Domyati Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate J Cosmet Derm 6 2007 119 124 (Pubitemid 46845422)
143. C. Acikel, E. Ulkur, and B. Celikoz Carbon dioxide laser resurfacing and thin skin grafting in the treatment of "stable and recalcitrant" vitiligo Plast Reconstr Surg 111 2003 1291 1298 (Pubitemid 36297432)
144. K. Agrawal, and A. Agrawal Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft Dermatol Surg 21 1995 295 300
145. M. Ozdemir, O. Cetinkale, R. Wolf, A. Kotogyan, C. Mat, and B. Tuzun Comparison of two surgical approaches for treating vitiligo: a preliminary study Int J Dermatol 41 2002 135 138 (Pubitemid 34601106)
146. S. Khandpur, V.K. Sharma, and Y. Manchanda Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo Dermatol Surg 31 2005 436 441 (Pubitemid 40489305)
147. R. Falabella, and M.I. Barona Update on skin repigmentation therapies in vitiligo Pigment Cell Melanoma Res 22 2009 42 65
148. B.R. Boersma, W. Westerhof, and J.D. Bos Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients J Am Acad Dermatol 33 1995 990 995
149. S. Malakar, and S. Dhar Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients Dermatology 198 1999 133 139 (Pubitemid 29204595)
150. M. Sachdev, and D.S. Shankar Dermatologic surgery: pulsed erbium: YAG laser-assisted autologous epidermal punch grafting in vitiligo Int J Dermatol 39 2000 868 871 (Pubitemid 32010945)
151. K. Lahiri, S. Malakar, N. Sarma, and U. Banerjee Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm) - a prospective study Int J Dermatol 45 2006 649 655 (Pubitemid 44056661)
152. K.D. Barman, B.K. Khaitan, and K.K. Verma A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo Dermatol Surg 30 2004 49 53 (Pubitemid 38174029)
153. V. Pandya, K.S. Parmar, B.J. Shah, and F.E. Bilimoria A study of autologous melanocyte transfer in treatment of stable vitiligo Indian J Dermatol Venereol Leprol 71 2005 393 397 (Pubitemid 41769421)
154. N. van Geel, K. Ongenae, M. De Mil, Y.V. Haeghen, C. Vervaet, and J.M. Naeyaert Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo Arch Dermatol 140 2004 1203 1208 (Pubitemid 39362237)
155. S.V. Mulekar Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation Int J Dermatol 44 2005 841 845 (Pubitemid 41535701)
156. S.V. Mulekar Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation Arch Dermatol 140 2004 1211 1215 (Pubitemid 39362238)
157. Y.F. Chen, J.S. Chang, P.Y. Yang, C.M. Hung, M.H. Huang, and D.N. Hu Transplant of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental vitiligo J Dermatol 27 2000 434 439 (Pubitemid 30620258)
158. E. Pianigiani, M. Risulo, A. Andreassi, P. Taddeucci, F. Ierardi, and L. Andreassi Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo Dermatol Surg 31 2005 155 159 (Pubitemid 40990942)
159. N. van Geel, K. Ongenae, Y. Vander Haeghen, C. Vervaet, and J.M. Naeyaert Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo Dermatology 213 2006 23 29
160. U.S. Agarwal, D. Jain, R. Gulati, P. Bhargava, and N.K. Mathur Silicone gel sheet dressings for prevention of post-minigraft cobblestoning in vitiligo Dermatol Surg 25 1999 102 104 (Pubitemid 30195946)
161. M.F. Grojean, J. Thivolet, and H. Perrot Acquired leukomelanoderma caused by topical depigmenting agents Ann Dermatol Venereol 109 1982 641 647
162. V. Hariharan, J. Klarquist, M.J. Reust, A. Koshoffer, M.D. McKee, and R.E. Boissy Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation J Invest Dermatol 130 2010 211 220
163. D.B. Mosher, J.A. Parrish, and T.B. Fitzpatrick Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature Br J Dermatol 97 1977 669 679
164. M.D. Njoo, R.M. Vodegel, and W. Westerhof Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser J Am Acad Dermatol 42 5 pt 1 2000 760 769 (Pubitemid 30252879)
165. J. Rao, and R.E. Fitzpatrick Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo Dermatol Surg 30 2004 1043 1045 (Pubitemid 38890917)
166. M. Thissen, and W. Westerhof Laser treatment for further depigmentation in vitiligo Int J Dermatol 36 1997 386 388 (Pubitemid 27278509)
167. J.J. Nordlund, B. Forget, J. Kirkwood, and A.B. Lerner Dermatitis produced by applications of monobenzone in patients with active vitiligo Arch Dermatol 121 1985 1141 1144 (Pubitemid 15018898)
168. T.R. Hedges 3rd, K.R. Kenyon, L.A. Hanninen, and D.B. Mosher Corneal and conjunctival effects of monobenzone in patients with vitiligo Arch Ophthalmol 101 1983 64 68 (Pubitemid 13167172)
169. K. Ongenae, L. Dierckxsens, L. Brochez, N. van Geel, and J.M. Naeyaert Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage Dermatology 210 2005 279 285 (Pubitemid 40976734)
170. G. Agarwal Vitiligo: an under-estimated problem Fam Pract 15 suppl 1 1998 S19 S23
171. A. Tedeschi, F. Dall'sOglio, G. Micali, R.A. Schwartz, and C.K. Janniger Corrective camouflage in pediatric dermatology Cutis 79 2007 110 112
172. S. Hsu Camouflaging vitiligo with dihydroxyacetone Dermatol Online J 14 2008 23
173. N. Rajatanavin, S. Suwanachote, and S. Kulkollakarn Dihydroxyacetone: a safe camouflaging option in vitiligo Int J Dermatol 47 2008 402 406 (Pubitemid 351486489)
174. H. Fesq, K. Brockow, K. Strom, M. Mempel, J. Ring, and D. Abeck Dihydroxyacetone in a new formulation - a powerful therapeutic option in vitiligo Dermatology 203 2001 241 243 (Pubitemid 33035983)
175. M. Tanioka, and Y. Miyachi Camouflaging vitiligo of the fingers Arch Dermatol 144 2008 809 810 (Pubitemid 351846892)
176. B.B. Mahajan, G. Garg, and R.R. Gupta Evaluation of cosmetic tattooing in localised stable vitiligo J Dermatol 29 2002 726 730 (Pubitemid 35416260)
177. L. Papadopoulos, R. Bor, and C. Legg Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy Br J Med Psychol 72 pt 3 1999 385 396 (Pubitemid 29465543)
178. A. Birol, U. Kisa, G.S. Kurtipek, F. Kara, M. Kocak, and E. Erkek Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo Int J Dermatol 45 2006 992 993 (Pubitemid 44145043)
179. J.A. Simon, and R. Burgos-Vargas Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab Dermatology 216 2008 234 235 (Pubitemid 351416724)
180. M. Wakkee, Y.J. Assen, H.B. Thio, and H.A. Neumann Repigmentation of vitiligo during efalizumab J Am Acad Dermatol 59 2 suppl. 1 2008 S57 S58
181. N. Al-Mutairi, and A. Al-Doukhi Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept J Cutan Med Surg 13 2009 172 175
182. D. Parsad, and A.J. Kanwar Oral minocycline in the treatment of vitiligo - a preliminary study Dermatol Ther 23 2010 305 307
183. M. Radmanesh, and K. Saedi The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients J Dermatolog Treat 17 2006 151 153 (Pubitemid 44147831)
184. S. Dogra, and B. Kumar Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir Dermatol Online J 11 2005 30
185. S.L. Pardue, K.V. Fite, L. Bengston, S.J. Lamont, M.L. Boyle 3rd, and J.R. Smyth Jr. Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration J Invest Dermatol 88 1987 758 761 (Pubitemid 17077750)
186. A.K. Gupta, C.N. Ellis, B.J. Nickoloff, M.T. Goldfarb, V.C. Ho, and L.L. Rocher Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis Arch Dermatol 126 1990 339 350 (Pubitemid 20094674)
187. D. Hossain Treatment of vitiligo with limited resources in Bangladesh J Am Acad Dermatol 49 2003 966 967 (Pubitemid 37314909)
188. S. Agarwal, M. Ramam, V.K. Sharma, S. Khandpur, H. Pal, and R.M. Pandey A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo Br J Dermatol 153 2005 163 166 (Pubitemid 41044543)
189. Epocrates Online Web site. Available from: https://online.epocrates.com/ home. Accessed June 1, 2011.
190. Drugstore Web site. Available from: www.drugstore.com. Accessed June 1, 2011.
191. S.M. Langan, A. Heerey, M. Barry, and L. Barnes Cost analysis of narrowband UVB phototherapy in psoriasis J Am Acad Dermatol 50 2004 623 626 (Pubitemid 38393174)
192. B. Grubb Treating vitiligo and psoriasis with the excimer laser JAAPA 21 2008 53 54
193. A. Taieb, M. Picardo VETF Members The definition and assessment of vitiligo: a consensus report of the vitiligo european task force Pigment Cell Res 20 2007 27 35 (Pubitemid 46090162)